Project Grant R01AG088646
Award Date 9/15/25
Completion Date 5/31/29
Dollars Obligated $683K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This Project Grant award of $182,187 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to characterize spatial access to Medications for Opioid Use Disorder (MOUD) and co-located mental health services, and determine their association with overdose mortality and MOUD treatment uptake and retention. The research will be conducted by The Johns Hopkins University over the project period from August 1, 2025 to July 31, 2030. The...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- The National Institute on Aging (NIA) awarded a $676,000 Project Grant under its Aging Research Federal Grant Program (CFDA 93.866) to the Icahn School of Medicine at Mount Sinai. The grant will fund research to study the unintended impact of the 2016 CDC opioid prescribing guidelines on disparities in opioid utilization among vulnerable subgroups of older adults, including those with Alzheimer's and related dementias, racial/ethnic minorities, and those experiencing socioeconomic deprivation....
- This Project Grant award of $722,917 from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, will fund a 5-year study to evaluate a new approach for dispensing methadone to incarcerated individuals with opioid use disorder (OUD) in three state prison systems. The project aims to support widespread implementation of the hospital/clinic designation, which allows carceral facilities to stock and dispense methadone for OUD treatment, by launching a...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is focused on evaluating the impact of state policies that facilitate the initiation of medication-based treatment for opioid use disorder (OUD) in emergency department settings. The $794,574 grant will fund a 5-year project to: 1) create a public database of state laws related to emergency department-based initiation of medications for OUD treatment; 2) analyze national...
- This $1,360,092 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to assess social functioning among individuals with opioid use disorder (OUD) and their concerned significant others (CSOs) during OUD treatment. The study will use ecological momentary assessment and a smartwatch-based application to collect both subjective self-reports and objective measurements of social behaviors, social...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a $636,957 study to investigate the relationship between prescription opioids, brain structure, and cognition in older adults with chronic pain. The single-center, double-blinded, placebo-controlled trial will enroll 200 participants with chronic pain due to osteoarthritis. The primary goal is to determine if opioid exposure is associated with changes in white matter integrity and global...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...
- This federal Project Grant award of $798,828.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to discover novel small molecule therapeutics for the safe and effective treatment of opioid use disorder (OUD). The key products and services to be delivered include: The development of an AI platform called M3.AI that will integrate target-based and phenotype-based methodologies to efficiently identify new drug candidates for OUD...